Vaccine News and Research

Latest Vaccine News and Research

Scientists identify inhibitors of key enzyme involved in survival of malaria parasite

An international team of scientists, led by researchers from the Department of Pediatrics at the University of California, San Diego School of Medicine, have identified the first reported inhibitors of a key enzyme involved in survival of the parasite responsible for malaria. Their findings, which may provide the basis for anti-malarial drug development, are currently published in the online version of the Journal of Medicinal Chemistry.

20 Jul 2012

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem’s live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem’s strategy, and this research is part of the work towards that goal.

19 Jul 2012

USA Today examines recent HIV breakthroughs

USA Today examines several scientific breakthroughs that researchers say "could be key to reducing new HIV infections." "Doctors are hopeful not because of a single discovery, but because of a string of breakthroughs over the past two or three years, says Diane Havlir, a professor at the University of California-San Francisco," the news service writes.

19 Jul 2012

Duke-led consortium to focus on inducing neutralizing antibodies for HIV-1 prevention

Two Los Alamos National Laboratory scientists are among the team recently funded to explore ways to create the precise immune factors needed for effective vaccines against HIV.

19 Jul 2012

Targets reached in Haiti's pilot cholera vaccination program, NPR reports

NPR's "Shots" blog reports on the results of a "high-visibility pilot project to vaccinate 100,000 Haitians against cholera." The blog writes, "Almost 90 percent of the target population -- half in Port-au-Prince and the other half in a remote rural area -- got fully protected against cholera, meaning they got two doses of the oral vaccine."

19 Jul 2012

Blog examines potential repercussions of CIA's fake vaccination campaign in Pakistan

In this post on her blog, "The Garrett Update," Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), examines the potential implications of a fake hepatitis vaccine campaign carried out by the CIA in Pakistan last year in an attempt to gather DNA from Osama bin Laden's family.

19 Jul 2012

Two polio campaign workers shot, wounded in Pakistan; WHO says no sign attack was deliberate

"Gunmen in Pakistan shot and wounded a staff member of the World Health Organization (WHO) and an expatriate consultant working for the United Nations health agency on Tuesday, the WHO said," Reuters reports.

19 Jul 2012

Duke receives Gates Foundation grant for HIV vaccine study

The Bill & Melinda Gates Foundation has awarded a new grant to Duke University Medical Center for work developing vaccines that can induce IgA antibodies for preventing HIV-1 infection. This award comes from the Gates' Collaboration for AIDS Vaccine Discovery (CAVD) program.

19 Jul 2012

CSIRO to produce antibodies for development of new vaccines against rotavirus

CSIRO has been contracted by PATH (Program for Appropriate Technology in Health) to produce antibodies on a large scale that will aid the development of new, safe, affordable and effective vaccines against rotavirus, a major cause of severe and fatal diarrhoea in young children worldwide.

18 Jul 2012

Vaccination more reliable than observation for bovine herpesvirus

Vaccination halts the circulation of bovine herpesvirus type 1 in dairy herds and should been seen as the best way to eradicate the virus, despite it disappearing without intervention in some herds after long periods, report researchers in the Veterinary Record.

18 Jul 2012

Combination prevention strategy trials to start later this year in Africa, GlobalPost reports

As part of its "AIDS Turning Point" series, GlobalPost examines how the United States and its African partners are designing clinical trials at four African sites to test whether a combination of prevention methods and strategies -- "notably the vaccine-like preventative effect on transmission when someone starts taking AIDS drugs, as well as the life-long protection afforded to many due to male circumcision" -- could "put them on the road to a Holy Grail: the numbers of HIV infections tumbling down."

18 Jul 2012

Researchers uncover mechanism by which aging may weaken immune response

Researchers at Albert Einstein College of Medicine of Yeshiva University have uncovered one of the mechanisms by which aging may compromise the ability of the immune system to fight infections and respond to vaccines.

18 Jul 2012

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Johnson & Johnson today announced sales of $16.5 billion for the second quarter of 2012, a decrease of 0.7% as compared to the second quarter of 2011. Operational results increased 3.5% and the negative impact of currency was 4.2%.

17 Jul 2012

Duke University to receive CHAVI-Immunogen Discovery grant for effective HIV vaccine

A large federal grant awarded to Duke University will fund a highly focused program to discover how to induce the precise immune factors needed for effective vaccines against HIV.

17 Jul 2012

Helper T cells may be frontline warriors when battling hepatitis A infection

Helper cells traditionally thought to only assist killer white blood cells may be the frontline warriors when battling hepatitis A infection. These are the findings from a Nationwide Children's Hospital study appearing in a recent issue of the Journal of Experimental Medicine.

17 Jul 2012

Drug treatments, scientific advances fuel hope for HIV control as AIDS 2012 conference draws near

"A cure for AIDS remains a distant prospect but a host of drug treatments and other advances have fueled fresh hope that new HIV infections may someday be halted for good," Agence France-Presse reports.

17 Jul 2012

Scientists discover new way to convert cord blood cells into iNC

For more than 20 years, doctors have been using cells from blood that remains in the placenta and umbilical cord after childbirth to treat a variety of illnesses, from cancer and immune disorders to blood and metabolic diseases.

17 Jul 2012

Gates Foundation's efforts to improve access to contraceptives will improve health, lives of women, children

"Supporters of women's health ought to cheer the Bill & Melinda Gates Foundation's plan" to provide $1 billion over eight years to increasing women's access to contraceptives and family planning services because the "effort underscores the critical role of family planning in the international battle to reduce poverty and improve maternal health," a Seattle Times editorial states.

17 Jul 2012

Pakistan polio immunization campaign might not reach 240,000 children because of militant leaders' bans on vaccine

A national polio vaccination campaign set to begin this week in Pakistan might not reach 240,000 children in the northwest because of a Taliban ban on the inoculations, Agence France-Presse reports. Local militant leaders "have banned polio vaccinations in the northwestern tribal region of Waziristan to protest against U.S. drone attacks" and "have condemned the immunization campaign, which is slated to begin on Monday, as a cover for espionage," the news agency writes.

17 Jul 2012

New CD141hi DC subset plays a critical role in activating immune response against pathogens

Scientists at A*STAR's Singapore Immunology Network (SIgN), in collaboration with Newcastle University, UK, the Singapore Institute of Clinical Sciences and clinicians from multiple hospitals in Singapore, have identified a new subset of dendritic cells (DCs) in human peripheral tissue which have a critical role in activating our immune response against harmful pathogens.

17 Jul 2012

Vaccine News and Research

Latest Vaccine News and Research

Scientists identify inhibitors of key enzyme involved in survival of malaria parasite

BioDiem signs agreement with RMIT to create new non-influenza vaccines

USA Today examines recent HIV breakthroughs

Duke-led consortium to focus on inducing neutralizing antibodies for HIV-1 prevention

Targets reached in Haiti's pilot cholera vaccination program, NPR reports

Blog examines potential repercussions of CIA's fake vaccination campaign in Pakistan

Two polio campaign workers shot, wounded in Pakistan; WHO says no sign attack was deliberate

Duke receives Gates Foundation grant for HIV vaccine study

CSIRO to produce antibodies for development of new vaccines against rotavirus

Vaccination more reliable than observation for bovine herpesvirus

Combination prevention strategy trials to start later this year in Africa, GlobalPost reports

Researchers uncover mechanism by which aging may weaken immune response

Johnson & Johnson second quarter sales decrease 0.7% to $16.5B

Duke University to receive CHAVI-Immunogen Discovery grant for effective HIV vaccine

Helper T cells may be frontline warriors when battling hepatitis A infection

Drug treatments, scientific advances fuel hope for HIV control as AIDS 2012 conference draws near

Scientists discover new way to convert cord blood cells into iNC

Gates Foundation's efforts to improve access to contraceptives will improve health, lives of women, children

Pakistan polio immunization campaign might not reach 240,000 children because of militant leaders' bans on vaccine

New CD141hi DC subset plays a critical role in activating immune response against pathogens

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in